No products in the cart.
New
Retatrutide-10mg (5mL Vial)
$233.75
Retatrutide is a novel and exceptionally potent polypeptide that represents a significant advancement in metabolic pharmacology. It is a unique triple-receptor agonist, concurrently activating the receptors for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon. This multi-agonist approach leverages the synergistic effects of these three distinct incretin hormones and a catabolic hormone to achieve unprecedented metabolic improvements.
Description
Quick Facts
Retatrutide 10mg (5mL Vial) is a premium, pharmaceutical-grade, lyophilized peptide designed exclusively for advanced laboratory research. As a cutting-edge triple agonist, Retatrutide simultaneously targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. This unique multi-receptor activity makes it a valuable tool for researchers studying metabolic disorders, including obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). Each vial contains 10mg of high-purity Retatrutide, rigorously tested to ensure >99% purity via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).
Key Features
- Purity: Verified at >99% through independent third-party HPLC and MS testing, ensuring consistent and reliable research outcomes.
- Composition: Supplied as a lyophilized powder in a 5mL sterile, borosilicate glass vial with a rubber stopper and aluminum seal for secure storage.
- Molecular Profile: Chemical Name: Retatrutide (LY3437943, sodium salt form); Molecular Formula: C221H342N46O68; Molecular Weight: 4731.33 g/mol; CAS Number: 2381089-83-2.
- Research Applications: Ideal for in vitro and in vivo non-human studies exploring metabolic regulation, weight management, glucose homeostasis, and energy expenditure.
Mechanism of Action
Retatrutide’s triple agonist profile activates GLP-1, GIP, and glucagon receptors, influencing multiple intracellular signaling pathways. This synergistic approach enhances glucose-dependent insulin secretion, promotes satiety, and increases energy expenditure, making it a breakthrough compound for metabolic research. Its prolonged action, achieved through structural modifications like DPP-IV resistance and albumin binding, supports once-weekly dosing in preclinical models, offering researchers flexibility in experimental design.
Storage and Handling
To maintain stability, store lyophilized Retatrutide at -4°F (-20°C) in a dry, dark environment. After reconstitution with bacteriostatic water or sterile saline, store at 36–46°F (2–8°C) and use within 30 days to prevent degradation. Avoid repeated freeze-thaw cycles to preserve peptide integrity. Handle vials carefully, ensuring the tamper-evident seal remains intact and the rubber stopper is sterilized before reconstitution.
Safety and Usage Disclaimer
Retatrutide is strictly for laboratory research and not intended for human or veterinary use, nor as a drug, dietary supplement, or cosmetic. Only qualified professionals should handle this product in controlled settings. Adhere to all relevant safety protocols to ensure proper use.
Why Choose Retatrutide 10mg?
Retatrutide 10mg (5mL Vial) offers researchers a high-purity, stable peptide for cutting-edge metabolic studies. Its triple agonist mechanism and robust stability make it an essential tool for advancing scientific understanding of energy regulation and metabolic health.
⚠️ *Important Notice: All peptides are supplied in a powdered (lyophilized) form. They must be reconstituted before use.
